E. Davis - Feb 12, 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
CEO and President, Director
Signature
Sean D. Mersten, Attorney in Fact for James E. Davis
Stock symbol
DGX
Transactions as of
Feb 12, 2025
Transactions value $
$0
Form type
4
Date filed
2/14/2025, 05:30 PM
Previous filing
Mar 1, 2024
Next filing
Feb 21, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award $0 +18.1K +14.41% $0.00 144K Feb 12, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Award $0 +69.6K $0.00 69.6K Feb 12, 2025 Common Stock 69.6K $165.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units.
F2 The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.